OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review
Ji Wen, Huifang Hu, Menglin Chen, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 26
Ji Wen, Huifang Hu, Menglin Chen, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis
Ilaria Maccora, Preston Land, Virginia Miraldi Utz, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 7, pp. 689-692
Open Access | Times Cited: 10
Ilaria Maccora, Preston Land, Virginia Miraldi Utz, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 7, pp. 689-692
Open Access | Times Cited: 10
Double-masked, dose-response, vehicle-controlled study of VVN461 ophthalmic solution in post-operative ocular inflammation
James H. Peace, Kevin Jong, Jason Bacharach, et al.
Ophthalmology Science (2025), pp. 100806-100806
Open Access
James H. Peace, Kevin Jong, Jason Bacharach, et al.
Ophthalmology Science (2025), pp. 100806-100806
Open Access
Uncovering potential biomarkers and metabolic pathways in systemic lupus erythematosus and lupus nephritis through integrated microbiome and metabolome analysis
Siyun Cheng, Xiaojie Chu, Zhongyu Wang, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
Siyun Cheng, Xiaojie Chu, Zhongyu Wang, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
Janus Kinase Inhibitors in the Treatment of Refractory Cicatrizing Conjunctivitis in Pemphigoid
Celine Nguyen, Ebuka Eziama, Arturo R. Domínguez, et al.
The Ocular Surface (2025)
Closed Access
Celine Nguyen, Ebuka Eziama, Arturo R. Domínguez, et al.
The Ocular Surface (2025)
Closed Access
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries
Antonio Vitale, Judith Palacios-Olid, Valeria Caggiano, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Antonio Vitale, Judith Palacios-Olid, Valeria Caggiano, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Challenges and management of childhood noninfectious chronic uveitis
Ilaria Maccora, Edoardo Marrani, Ilaria Pagnini, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 6, pp. 599-611
Closed Access | Times Cited: 8
Ilaria Maccora, Edoardo Marrani, Ilaria Pagnini, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 6, pp. 599-611
Closed Access | Times Cited: 8
Beneficial Effect of Upadacitinib in an Adult Patient with Juvenile Idiopathic Arthritis-associated Uveitis after Unsatisfactory Response to Tofacitinib: A Case Report
Karoline Walscheid, Carsten Heinz, Timo Räth, et al.
Ocular Immunology and Inflammation (2022) Vol. 31, Iss. 5, pp. 1079-1080
Closed Access | Times Cited: 12
Karoline Walscheid, Carsten Heinz, Timo Räth, et al.
Ocular Immunology and Inflammation (2022) Vol. 31, Iss. 5, pp. 1079-1080
Closed Access | Times Cited: 12
Pediatric uveitis: Role of the pediatrician
Abhay Shivpuri, Inga Turtsevich, Ameenat Lola Solebo, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 12
Abhay Shivpuri, Inga Turtsevich, Ameenat Lola Solebo, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 12
Atopische Keratokonjunktivitis: Pathophysiologie, Klinik und potenzielle neue Therapiekonzepte
Thabo Lapp, Caroline Mann, Thilo Jakob, et al.
Klinische Monatsblätter für Augenheilkunde (2024) Vol. 241, Iss. 05, pp. 607-618
Closed Access | Times Cited: 2
Thabo Lapp, Caroline Mann, Thilo Jakob, et al.
Klinische Monatsblätter für Augenheilkunde (2024) Vol. 241, Iss. 05, pp. 607-618
Closed Access | Times Cited: 2
The management of adult and paediatric uveitis for rheumatologists
Sarah L. N. Clarke, Panagiotis Maghsoudlou, Catherine Guly, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 12, pp. 795-808
Closed Access | Times Cited: 2
Sarah L. N. Clarke, Panagiotis Maghsoudlou, Catherine Guly, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 12, pp. 795-808
Closed Access | Times Cited: 2
Behçet uveitis: Current practice and future perspectives
Shereen Hassan Aboul Naga, Lameece Moustafa Hassan, Radwa T. El Zanaty, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Shereen Hassan Aboul Naga, Lameece Moustafa Hassan, Radwa T. El Zanaty, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Gut microbiota mediated the effects of high relative humidity on lupus in female MRL/lpr mice
Chaochao Wang, Yongqiang Lin, Leiming Chen, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 5
Chaochao Wang, Yongqiang Lin, Leiming Chen, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 5
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients
Ai Tien Nguyen, Isabelle Koné‐Paut, Perrine Dusser
Pediatric Drugs (2023) Vol. 26, Iss. 1, pp. 31-47
Closed Access | Times Cited: 5
Ai Tien Nguyen, Isabelle Koné‐Paut, Perrine Dusser
Pediatric Drugs (2023) Vol. 26, Iss. 1, pp. 31-47
Closed Access | Times Cited: 5
Utility of tocilizumab in autoimmune eye diseases
Belén Atienza‐Mateo, D. Prieto-Peña, Esther F. Vicente‐Rabaneda, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 789-799
Closed Access | Times Cited: 8
Belén Atienza‐Mateo, D. Prieto-Peña, Esther F. Vicente‐Rabaneda, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 789-799
Closed Access | Times Cited: 8
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility
Heeren M. Gordhan, Steven T. Miller, Daphne C. Clancy, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8929-8950
Closed Access | Times Cited: 4
Heeren M. Gordhan, Steven T. Miller, Daphne C. Clancy, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8929-8950
Closed Access | Times Cited: 4
Managing psoriatic arthritis in different clinical scenarios
Rubén Queiró, Marta Loredo, Ignacio Braña, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1469-1484
Closed Access | Times Cited: 4
Rubén Queiró, Marta Loredo, Ignacio Braña, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1469-1484
Closed Access | Times Cited: 4
Successful treatment of psoriasis-associated uveitis with ixekizumab after failure of secukinumab and risankizumab
Angelyn Chen Yin Lua, Soon‐Phaik Chee, Hazel H. Oon
Singapore Medical Journal (2024)
Open Access | Times Cited: 1
Angelyn Chen Yin Lua, Soon‐Phaik Chee, Hazel H. Oon
Singapore Medical Journal (2024)
Open Access | Times Cited: 1
Long-Term Outcome of Tofacitinib Treatment for Systemic Autoimmune Disease-Associated Refractory Scleritis
Chung Young Kim, Eun Bong Lee, Joo Youn Oh
Ocular Immunology and Inflammation (2024), pp. 1-5
Closed Access | Times Cited: 1
Chung Young Kim, Eun Bong Lee, Joo Youn Oh
Ocular Immunology and Inflammation (2024), pp. 1-5
Closed Access | Times Cited: 1
Beneficial Effect of Upadacitinib in a Refractory Course of Scleritis: A Case Report
Karoline Walscheid, Carsten Heinz, Arnd Heiligenhaus
Ocular Immunology and Inflammation (2022), pp. 1-3
Closed Access | Times Cited: 4
Karoline Walscheid, Carsten Heinz, Arnd Heiligenhaus
Ocular Immunology and Inflammation (2022), pp. 1-3
Closed Access | Times Cited: 4
Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation
Theodoros Dimitroulas
Mediterranean Journal of Rheumatology (2023) Vol. 34, Iss. 3, pp. 282-282
Open Access | Times Cited: 1
Theodoros Dimitroulas
Mediterranean Journal of Rheumatology (2023) Vol. 34, Iss. 3, pp. 282-282
Open Access | Times Cited: 1
Uveitis in rheumatic diseases — therapeutic management
Artur Bachta, Anna Byszewska, Robert Kruszewski, et al.
Rheumatology Forum (2023) Vol. 9, Iss. 3, pp. 112-118
Open Access | Times Cited: 1
Artur Bachta, Anna Byszewska, Robert Kruszewski, et al.
Rheumatology Forum (2023) Vol. 9, Iss. 3, pp. 112-118
Open Access | Times Cited: 1
Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis
Zheng Xian Thng, Jonathan Regenold, Albert John Bromeo, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 2, pp. 95-104
Closed Access
Zheng Xian Thng, Jonathan Regenold, Albert John Bromeo, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 2, pp. 95-104
Closed Access
Janus Kinase Inhibitors as a Third-Line Therapy for Refractory Endogenous Noninfectious Uveitis
Justus G. Garweg, Kim A. Straessle
Ocular Immunology and Inflammation (2024), pp. 1-8
Closed Access
Justus G. Garweg, Kim A. Straessle
Ocular Immunology and Inflammation (2024), pp. 1-8
Closed Access
Treatment options for necrotizing scleritis in rheumatoid arthritis patients
Jessica A. Kraker, Wendy M. Smith
Expert Review of Ophthalmology (2024) Vol. 19, Iss. 5, pp. 357-377
Closed Access
Jessica A. Kraker, Wendy M. Smith
Expert Review of Ophthalmology (2024) Vol. 19, Iss. 5, pp. 357-377
Closed Access
